Inventor · disambiguated record
Pier Vincenzo Piazza
Also filed as: PIAZZA PIER VINCENZO
6 granted patents·8 pending applications·9 citations·filing 2004–2022
76Inventor score
Top patents by PatentIndex Score
14 records- 0177US11484537B23β-(4-methoxybenzyloxy)pregn-5-en-20-one for use in the treatment of cannabinoids-related disordersAELIS FARMA·Filed 2019·Granted Nov 1, 2022·2 cites·19 claims
- 0275US10259839B23-(4′-substituted)-benzyl-ether derivatives of pregnenoloneINST NAT SANTE RECH MED·Filed 2013·Granted Apr 16, 2019·3 cites·4 claims
- 0375US10040816B2Antagonists of CB1 receptorINST NAT SANTE RECH MED·Filed 2016·Granted Aug 7, 2018·3 cites·18 claims
- 0463US12447159B23β-(4-methoxybenzyloxy)pregn-5-en-20-one for use in the treatment of Cannabinoids-Related DisordersAELIS FARMA·Filed 2022·Granted Oct 21, 2025·0 cites·24 claims
- 0563US2022153776A1Antagonists of cb1 receptorINST NAT SANTE RECH MED·Filed 2021·Application pending·0 cites
- 0661US2021230211A13-(4'-substituted)-benzyl-ether derivatives of pregnenoloneINST NAT SANTE RECH MED·Filed 2020·Application pending·0 cites
- 0760US10150793B2Antagonists of CB1 receptorPIAZZA PIER VINCENZO·Filed 2012·Granted Dec 11, 2018·1 cites·2 claims
- 0856US2007042445A1Method for demonstration of a molecular event in a cell by means of fluorescent marker proteinsINST NAT SANTE RECH MED·Filed 2004·Application pending·0 cites
- 0953US2019202857A13-(4'-substituted)-benzyl-ether derivatives of pregnenoloneINSERM LNSTITUT NATIONAL DE LA SANTE ET DE LA RECH MEDICALE·Filed 2019·Application pending·0 cites
- 1050US2023305023A1Methods of treatment and diagnostic of pathological conditions associated with intense stressINST NAT SANTE RECH MED·Filed 2021·Application pending·0 cites
- 1150US2017226148A13-(4'-substituted)-benzyl-ether derivatives of pregnenoloneINSERM (INSTITUT NAT DE LA SANTE ET DE LA RECH MEDICALE)·Filed 2017·Application pending·0 cites
- 1248US2019071465A1Antagonists of cb1 receptorPIAZZA PIER VINCENZO·Filed 2018·Application pending·0 cites
- 1345US2012040389A1Method for demonstration of a molecular event in a cell by means of fluorescent marker proteinsICHAS FRANCOIS·Filed 2011·Application pending·0 cites
- 1440US9468646B2Increased dosage of efavirenz for the treatment of cancerALIENOR FARMA·Filed 2013·Granted Oct 18, 2016·0 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when Pier Vincenzo Piazza files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →